CONMED - CNMD Stock Forecast, Price & News

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CONMED in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" CNMD shares.
View CNMD analyst ratings or view top-rated stocks.

2 Wall Street research analysts have issued 1-year target prices for CONMED's shares. Their CNMD share price forecasts range from $118.00 to $122.00. On average, they predict the company's share price to reach $120.00 in the next twelve months. This suggests a possible upside of 16.9% from the stock's current price.
View analysts price targets for CNMD or view top-rated stocks among Wall Street analysts.

CONMED's stock was trading at $88.64 at the beginning of 2023. Since then, CNMD stock has increased by 15.8% and is now trading at $102.61.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 3rd 2023.
View our CNMD earnings forecast.

CONMED Co. (NYSE:CNMD) released its earnings results on Thursday, February, 2nd. The company reported $0.42 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.93 by $0.51. The company earned $250.87 million during the quarter, compared to analysts' expectations of $302.48 million. CONMED had a positive trailing twelve-month return on equity of 11.47% and a negative net margin of 7.71%. The firm's revenue was down 8.4% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.07 EPS.

CONMED announced a quarterly dividend on Monday, December 5th. Investors of record on Friday, December 16th will be given a dividend of $0.20 per share on Thursday, January 5th. This represents a $0.80 dividend on an annualized basis and a yield of 0.78%. The ex-dividend date of this dividend is Thursday, December 15th.
Read our dividend analysis for CNMD.

CONMED (NYSE:CNMD) pays an annual dividend of $0.80 per share and currently has a dividend yield of 0.75%.
Read our dividend analysis for CNMD.

CONMED issued an update on its first quarter 2023 earnings guidance on Friday, February, 3rd. The company provided earnings per share (EPS) guidance of $0.58-$0.63 for the period, compared to the consensus EPS estimate of $0.61. The company issued revenue guidance of $262.00 million-$272.00 million, compared to the consensus revenue estimate of $268.73 million.

CONMED trades on the New York Stock Exchange (NYSE) under the ticker symbol "CNMD."

CONMED's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Fisher Asset Management LLC (1.13%), New York State Common Retirement Fund (0.98%), Congress Asset Management Co. MA (0.55%), Mountain Pacific Investment Advisers Inc. ID (0.41%), Peregrine Capital Management LLC (0.38%) and Moody Aldrich Partners LLC (0.17%).
View institutional ownership trends.

Shares of CNMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CNMD stock can currently be purchased for approximately $102.61.

CONMED (NYSE:CNMD) has a market capitalization of $3.13 billion and generates $1.05 billion in revenue each year. The company earns $62.54 million in net income (profit) each year or ($2.84) on an earnings per share basis.

The company employs 3,800 workers across the globe.

CONMED's mailing address is 525 FRENCH ROAD, UTICA NY, 13502. The official website for the company is www.conmed.com. The company can be reached via phone at (727) 392-6464 or via fax at 315-797-0321.